ANAPTYSBIO, INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $234.6 | $91.3 | $17.2 | $10.3 | $63.2 |
| Operating income | $47.9 | -$114.9 | -$164.4 | -$115.2 | -$56.8 |
| Net income | -$13.2 | -$145.2 | -$163.6 | -$128.7 | -$57.8 |
| Cash Flow Statement | |||||
| Free cash flow | $19.6 | -$135.7 | -$121.6 | -$74.0 | -$47.3 |
| Share repurchases | $68.6 | $0.5 | $50.0 | $0.0 | $0.0 |
Shares outstanding 29.1M · Free float 17.7%
Annual filing data through FY ended December 31, 2025; float as of October 11, 2026.